Switching from the original etanercept (the originator) to an etanercept biosimilar for rheumatoid arthritis (RA) – patients do just as well as those who remained on the originator.

Switching from the original etanercept (the originator) to an etanercept biosimilar for rheumatoid arthritis (RA) – patients do just as well as those who remained on the originator.

by | Jan 17, 2024 | Research, Study results

BSRBR-RA study blog BSRBR-RA Study website ? Switching from the original etanercept (the originator) to an etanercept biosimilar for rheumatoid arthritis (RA) – patients do just as well as those who remained on the originator. Researchers: Lianne Kearsley-Fleet,...
The University of Manchester